Risk Factors Update Summary
- Facing competition from providers of alternative medical therapies, such as pharmaceutical companies.
- Undergoing a multi-year phased conversion to upgrade global ERP system, requiring significant resources.
- Subject to stricter standards for ethylene oxide emissions, with potential impacts on operations.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=96943&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.